10 employees
Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
2011
$2.1M
from 2 investors over 2 rounds
Oncofactor Corporation raised $2.1M on August 2, 2011
Investors: Washington Research Foundation and ARCH Venture Partners